INFIPLAST
French polymer transformation specialist founded in 1989 providing co-design-to-industrialization injection molding services for industrial OEMs (automotive, aeronautics, railway, home automation) and medical device customers (ophthalmology, surgery, oncology, diagnostic, respiratory), operating ISO 5/7/8 clean rooms and holding ISO 13485, IATF 16949, and ISO 9001 certifications.
- Company typePrivate
- Founded1989
- HeadquartersOyonnax, France
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What INFIPLAST does
INFIPLAST SAS is a French polymer transformation specialist founded in 1989 and headquartered in Oyonnax (Veyziat), France, with a wholly-owned subsidiary in Taicang, China established in 2019. The company operates two divisions — INFIPLAST Industry (serving automotive, aeronautics, railway, and home automation) and INFIPLAST Biomedical (serving ophthalmology, surgery, oncology, and diagnostic applications) — providing end-to-end engineering support from co-design and material selection through industrialization, packaging, sterilization management, and CE marking. Core technology centers on precision injection molding, including a 550T press operating in an ISO 7 clean room, alongside ISO 5, 7, and 8 classified clean room infrastructure; the company holds ISO 9001:2015, IATF 16949:2016, and ISO 13485:2016 certifications supporting both industrial and medical-device customers.
The business model is project-based B2B contract manufacturing sold via direct enterprise field sales with quote-based custom pricing. Revenue streams span custom polymer sub-assemblies for industrial OEMs and full-service medical device production, including the proprietary PROPIUM brand of respiratory filters (heat and moisture exchange filters and antibacterial/antiviral filters) that INFIPLAST industrialized in 15 days during the COVID-19 response to reconstitute a 100% French manufacturing source. The company monetizes through one-off project contracts and recurring manufacturing volume, distributing through direct engagement with global industry leaders and healthcare professionals, with supporting presence at trade shows such as Pharmapack.
Recent strategic activity is concentrated on biomedical scale-up: a 3,000 m² facility expansion announced in 2024–2025 adding 1,500 m² of clean rooms, a second single-use medical device unit commissioned in 2022 supported by France Relance sovereign-industry funding, and a strategic equity stake and co-development partnership with medtech startup ORIXHA in liquid ventilation. No revenue figures, headcount totals, or AI/ML capabilities are disclosed in available sources.
INFIPLAST firmographics
Firmographics- Name
- INFIPLAST
- Legal name
- INFIPLAST SAS
- Website
- https://infiplast.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- French polymer transformation specialist founded in 1989 providing co-design-to-industrialization injection molding services for industrial OEMs (automotive, aeronautics, railway, home automation) and medical device customers (ophthalmology, surgery, oncology, diagnostic, respiratory), operating ISO 5/7/8 clean rooms and holding ISO 13485, IATF 16949, and ISO 9001 certifications.
- Ownership category
- akta.pro rank
INFIPLAST industry classification
Industry- Product category
- Plastic Injection Molding Services
- NAICS
- Plastics Product Manufacturing (3261), Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Plastics Products, Nec (3089), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom) (IMANAFAC)
- akta.pro secondary industries
- Custom Injection Molding & Contract Manufacturing (Job Shops/CMs) (IMANAFAJ), Industrial & Machinery Injection Molded Components (Gears, Wear Parts) (IMANAFAF)
Keywords
Where INFIPLAST is headquartered
LocationHeadquarters
- HQ city
- Oyonnax
- HQ country
- France
- HQ region
- Europe
Offices3 records
Markets served
INFIPLAST business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
Revenue model
- Medical Device Manufacturing: Design, development, and manufacturing of medical devices including respiratory filters, surgical devices, ophthalmology devices, oncology equipment, and diagnostic tools. Revenue from product sales and full-service manufacturing contracts.
- Industrial Sub-assemblies: Co-conception, development, and industrialization of polymer sub-assemblies for automotive, aeronautics, railway, and home automation sectors. Provides complete engineering services from design through production.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
INFIPLAST product offering
Product offeringCore offering
INFIPLAST is a French polymer transformation specialist offering end-to-end contract manufacturing services — from co-design and material selection through development, industrialization, packaging, sterilization management, and CE marking — for medical devices and industrial sub-assemblies. The company operates injection molding up to 550T within ISO 5/7/8 clean rooms and serves clients in automotive, aeronautics, railway, home automation, ophthalmology, surgery, oncology, and diagnostics through its INFIPLAST Industry and INFIPLAST Biomedical divisions.
Product overview
INFIPLAST is a French polymer transformation company operating in two main divisions: INFIPLAST Industry (automotive, aeronautics, railway, home automation) and INFIPLAST Biomedical (ophthalmology, surgery, oncology, diagnostic). The company offers comprehensive engineering consulting from co-design through industrialization, packaging, and sterilization management. Key products include the PROPIUM brand of respiratory filters (HMEF) for medical use, along with specialized polymer solutions for various industrial and medical sectors. The company manufactures in clean room environments (ISO5, ISO7, ISO8) and holds relevant medical device certifications including CE marking.
Differentiator
Problem solved
Functional benefit
Brands
- PROPIUM: Brand of respiratory filters for ventilators, developed and manufactured in France during COVID-19 pandemic for distribution throughout France.
Products and services
- INFIPLAST Industry (Contract Polymer Manufacturing for Industrial Sub-assemblies) End-to-end contract polymer manufacturing service for industrial OEMs in automotive, aeronautics, railway, and home automation sectors. Includes co-design, material selection, development, industrialization, packaging, and quality certification (IATF 16949) for embedded polymer sub-assemblies such as thermal energy systems, adBlue components, hybrid power parts, electrical wiring, and interior train components.
- INFIPLAST Biomedical (Contract Manufacturing of Polymer Medical Devices) Contract development and manufacturing service for sterile, CE-marked polymer medical devices for ophthalmology, surgery, oncology, diagnostic, and respiratory applications. Includes clean room manufacturing (ISO 5/7/8), automated assembly, sterilization management, and CE marking support under ISO 13485 certification.
- PROPIUM Respiratory Filters Heat and Moisture Exchange (HMEF) and antibacterial/antiviral respiratory filters for anesthesia and intensive care ventilation, branded PROPIUM and 100% manufactured in France with CE marking. Sold to healthcare establishments including French hospitals.
Quantifiable outcome
- Developed and industrialized PROPIUM respiratory filters in 15 days with necessary market approvals during COVID-19
- +2 more outcomes
Companies that use INFIPLAST
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles2 records
INFIPLAST technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
INFIPLAST partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- SFAR (Société Française d'Anesthésie et de Réanimation)coreJoint e-symposium organization to deepen knowledge about heat and moisture exchange filters (HMEF) with participation of medical experts Pr Jaber, Dr De Jong, and Pr Constantin. Focused on respiratory filter education and COVID-19 recommendations.
- ORIXHAcoreINFIPLAST supports ORIXHA innovation in liquid ventilation development. INFIPLAST invested in ORIXHA capital and brings its expertise in medical devices. ORIXHA is a dynamic medtech startup with collaborative and societal participation developing fluid ventilation solutions.
- City of Oyonnax PartnershipminorPartnership with city of Oyonnax hosting Japanese delegation from Tsu region. Japanese delegation led by Mr. Yoshiaki HIDAKA, CEO of Azumi Techno, met INFIPLAST teams to discover organization and precision crafts for medical device manufacturing.
Scale indicators5 records
Recent moves9 records
Expansion highlights6 records
INFIPLAST competitors and assessment
Company assessmentDirect peers
- AptarGroup: US-headquartered global supplier of dispensing systems, sealing solutions, and active material science solutions for pharmaceutical, beauty, food, and home care markets. Comparable as a polymer-component specialist serving pharmaceutical packaging and respiratory device markets, including HMEF-style filtration components.
- Stevanato Group: Italian-based global provider of drug containment, drug delivery, and diagnostic solutions with proprietary injection molding and clean room manufacturing for medical devices and pharmaceutical applications. Directly comparable as a mid-to-large specialty injection molder serving the same medical device OEM customer base with clean room-driven capabilities.
- Groupe Lemoine: French manufacturer of plastic-based medical devices and pharmaceutical packaging with injection molding and clean room capabilities. Comparable as a fellow French mid-sized polymer specialist serving European medical device and pharmaceutical customers.
- Gerresheimer: German-headquartered manufacturer of primary packaging and drug delivery devices made of glass and plastics for the pharma and healthcare industries. Comparable as a European plastics-based medical device manufacturer with clean room capabilities serving similar pharmaceutical and medical device customers.
- Sonceboz: Swiss precision manufacturer specializing in plastic and mechatronic sub-assemblies for medical devices, automotive, and industrial applications. Comparable as a mid-sized European custom injection molder serving medical and industrial OEMs with clean room capabilities.
- Symatese: French-headquartered medical device manufacturer with expertise in biomaterials, implants, and polymer-based devices for surgery and aesthetics. Comparable as a mid-sized French specialty medical manufacturer with polymer processing capabilities and overlapping surgical/oncology device segments.
- Vygon: French-headquartered global medical device company specializing in single-use sterile and invasive products for hospitals. Comparable as a French medical device specialist with overlapping surgical, oncology, and respiratory-related product portfolios and similar European clean room manufacturing requirements.
- Nemera: French-headquartered medical device manufacturer specializing in drug delivery, ophthalmic, and respiratory devices with in-house plastic injection molding and clean room assembly. Highly comparable as a French/European peer operating in the same medical device categories (ophthalmology, respiratory) with overlapping customer base.
Broad incumbents
- West Pharmaceutical Services: US-headquartered global manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Comparable as a much larger established player in medical-grade polymer components with overlapping respiratory and injectable device customer base.
- Plastic Omnium: French-headquartered global leader in plastic solutions for automotive (clean energy, intelligent systems) and broader mobility markets. Comparable as a much larger French plastics specialist with automotive sector overlap, but lacking the medical device specialization that distinguishes INFIPLAST.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
INFIPLAST compliance and trust
Trust signalCompliance3 records
INFIPLAST financial estimates
Financial estimateRevenue estimate
Valuation estimate
INFIPLAST leadership team
Management profileNumber of profiles
Profiles1 record
INFIPLAST subsidiaries and ownership
Company hierarchySubsidiaries1 record
INFIPLAST funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
INFIPLAST M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about INFIPLAST
What does INFIPLAST do?
INFIPLAST is a French polymer transformation specialist offering end-to-end contract manufacturing services — from co-design and material selection through development, industrialization, packaging, sterilization management, and CE marking — for medical devices and industrial sub-assemblies. The company operates injection molding up to 550T within ISO 5/7/8 clean rooms and serves clients in automotive, aeronautics, railway, home automation, ophthalmology, surgery, oncology, and diagnostics through its INFIPLAST Industry and INFIPLAST Biomedical divisions.
Is INFIPLAST a public or private company?
INFIPLAST is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was INFIPLAST founded?
INFIPLAST was founded in 1989. It employs 51 to 100 people.
Where is INFIPLAST based?
INFIPLAST is headquartered in Oyonnax, France, in the Europe region.
How does INFIPLAST make money?
Two revenue lines are on record. Medical Device Manufacturing is the primary driver. The others are industrial Sub-assemblies.
Who are INFIPLAST's main competitors?
Direct peers on record are AptarGroup, Stevanato Group, Groupe Lemoine, Gerresheimer, Sonceboz, Symatese, Vygon and Nemera. Broad incumbents are West Pharmaceutical Services and Plastic Omnium.
Does INFIPLAST have an API?
No public API is recorded for INFIPLAST.
What industry is INFIPLAST in?
INFIPLAST's product category is Plastic Injection Molding Services. Its primary akta.pro industry code is IMANAFAC, Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom), with a secondary code of IMANAFAJ, Custom Injection Molding & Contract Manufacturing (Job Shops/CMs). Its NAICS code is 3261 and its SIC code is 3089.